U.S. FDA Approves First Generic Version of Levaquin (MYL) (RDY) (TEVA) (AKRX)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. SPCX
7. AVGO
8. HD
9. BJ
10. BABA

Go back to U.S. FDA Approves First Generic Version of Levaquin (MYL) (RDY) (TEVA) (AKRX)
Akorn, Inc. (NASDAQ: AKRX) Delayed: 0.09 --0 (-0%)
Previous Close $0.09    52 Week High $39.46 
Open $308.50    52 Week Low $17.57 
Day High $0.09    P/E 0.23 
Day Low $0.09    EPS $0.40 
Volume 532,651       

Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

DR. REDDY'S LAB LTD ADR (NYSE: RDY) Delayed: 12.18 +0.07 (0.58%)
Previous Close $12.11    52 Week High $54.73 
Open $12.13    52 Week Low $40.68 
Day High $12.23    P/E N/A 
Day Low $12.07    EPS $0.00 
Volume 2,020,640       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 37.34 +0.53 (1.44%)
Previous Close $36.81    52 Week High $66.55 
Open $36.79    52 Week Low $37.82 
Day High $37.75    P/E N/A 
Day Low $36.65    EPS $0.00 
Volume 4,300,152